AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT01970826 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Single Dental Implants
Description: place single unit dental implants, 2 mm below crestal bone and follow manufacturer guidelines.
Study NCT01970826 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Sterilized Aseptic
Description: Operatory room will be prepared totally aseptic
Study NCT01970826 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Sterilized Clean
Description: Operatory room will be prepared clean but not aseptic
Study NCT01309360 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: prilocaine 1%
Description: 40 outpatients : 40ml prilocaine 1% were administered for axillary plexus block
Study NCT01309360 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: prilocaine 1%
Description: 40 outpatients : 30ml prilocaine 1% were administered for axillary plexus block
Study NCT01309360 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: prilocaine 1%
Description: 40 outpatients : 20ml prilocaine 1% were administered for axillary plexus block
Study NCT01970826 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Full-Mouth Dental Implants
Description: dental implants for full-mouth implant rehabilitation.
Study NCT01970826 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Full-Mouth Dental Implants
Description: dental implants for full-mouth implant rehabilitation.
Study NCT01970826 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Partial Rehabilitation
Description: two or more implants to support partial rehabilitation
Study NCT01970826 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Partial Rehabilitation
Description: two or more implants to support partial rehabilitation
Study NCT01970826 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Duration of Surgery
Description: it will be measure the amount of time to perform the dental implant surgery. It will be measured from the time that the surgeon does the first incision until the last suture is made.
Study NCT01970826 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Duration of Surgery
Description: it will be measure the amount of time to perform the dental implant surgery. It will be measured from the time that the surgeon does the first incision until the last suture is made.
Study NCT02157805 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: beef meat
Description: Meat cooking conditions~1. st condition : beef meat cooked during 5 minutes at 55°C~2. nd condition : beef meat cooked during 30 minutes à 90°C
Study NCT02464189 — intervention group
Intervention type: OTHER
Intervention: Q-Kap
Study NCT04337814 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: EMLA Cream
Description: Topical anaesthetic cream
Study NCT04337814 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ibuprofen
Description: Oral analgesic syrup (non-steroidal anti inflammatory drug)
Study NCT04337814 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo syrup
Description: Placebo syrup similar to Ibuprofen
Study NCT03297645 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: School
Description: CHWs will ensure that families submit required health paperwork (e.g., asthma action plan, medication release form) and confirm with school nurses that children have the appropriate medications. School nurses will be given a standardized protocol to follow with clear guidelines for caring for students with asthma. The CHW assigned to the family will work with the school nurse to ensure that communication with the medical provider is occurring.
Study NCT03297645 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Asthma education
Description: CHWs will deliver evidence-based asthma education to parents and children. Content is drawn from existing asthma management programs, and adapted for families in Richmond. Between sessions, CHWs will call parents at least monthly to check in and assess family asthma management, including healthcare utilization since the last contact.
Study NCT04337814 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo cream
Description: Placebo cream similar to EMLA
Study NCT04337814 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo cream
Description: Placebo cream similar to EMLA
Study NCT00506064 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Melatonin
Description: 0.15 mg/kg by mouth (PO) Daily
Study NCT00506064 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Two, three, or four starch tablet or capsules before bed
Study NCT00506064 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaire
Description: Sleep study surveys, two per day completed each evening, lasting 10 minutes
Study NCT00506064 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Questionnaire
Description: Sleep study surveys, two per day completed each evening, lasting 10 minutes
Study NCT03535935 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Astragalus Powder
Description: 3 grams of water soluble astragalus sachets (equivalent to 15g raw herbs) administrated orally on top of standard medical care for 48 weeks.~Patients will have 5 days of medicine per week and will be advised to take the medicine once daily dissolved in boiling water in the first 5 days of the week.
Study NCT03535935 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Routine medical care (active comparator)
Description: Angiotensin converting enzyme inhibitor or angiotensin receptor blocker
Study NCT03535935 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Routine medical care (active comparator)
Description: Angiotensin converting enzyme inhibitor or angiotensin receptor blocker
Study NCT03355326 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Glycerin Suppository
Description: Glycerin suppository is given once daily beginning after conditions described are met and continued until discontinue conditions are met.
Study NCT04575636 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: Magnetic Resonance Lymphography
Description: Magnetic Resonance Lymphography using Siemens 3T MRI unit and Gadobutrol as a contrast agent to visualize the lymphatic system
Study NCT02271958 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Mifepristone
Study NCT02271958 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PLACEBO
Study NCT03297645 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Home environmental remediation
Description: Healthy Homes will complete home-based environmental assessments using evidence-based protocols. Healthy Homes will provide real-time education and share information about their findings and recommendations for action. Families are provided with low-cost intervention materials (e.g., filters, pillow covers), as well as behavioral modifications to aid in the reduction of asthma triggers in the home.
Study NCT03297645 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Informational mail
Description: Family will be mailed publicly available asthma information every 3 months.
Study NCT00818753 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dabigatran 110 mg
Description: comparison of different dabigatran dosages with unfractionated heparin
Study NCT00818753 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: dabigatran 150 mg
Description: comparison of different dabigatran dosages with unfractionated heparin
Study NCT00818753 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: unfractionated heparin
Description: comparison of different dosages dabigatran with unfractionated heparin
Study NCT02186860 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CAR-T cells
Description: Given IV
Study NCT03710915 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HG146
Description: HG146 will be administered every other day for 14 days, followed by 1 week off the drug with each treatment cycle of 21-days.
Study NCT04080622 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Selenium
Description: Selenium 300 µg/day (IV infusion)
Study NCT04080622 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebos
Description: NaCl 0,9% (IV infusion)
Study NCT03647358 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PET/CT Scan
Description: Up to four whole-body PET scans (approximately 24, 48, and 120 hours post 124I oral dose) will be performed on one of the GE Discovery 710 or 690 PET scanners.
Study NCT03647358 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Iodine-124
Description: Patients will receive 0.9 mg injections of rhTSH on two consecutive days. Twenty-four hours after the last injection of rhTSH each patient will receive approximately 5 mCi (range: 4-7 mCi) of 124I orally as a single dose.
Study NCT01155180 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Leptin
Description: Hormone - daily self injections for 6 months
Study NCT01155180 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study NCT01007721 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fluticasonepropionate nasal spray 200 mcg
Description: Fluticasonepropionate nasal spray 200 mcg (qd, 2 puffs of 50 mcg per nostril)
Study NCT03042559 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Protonics Knee brace
Description: The Protonics system has been introduced to physical therapists as a potential treatment for PFPS. The system includes a brace set to resist knee flexion and a set of specific exercises to perform daily. Through resistance to knee flexion, the system is advertised to decrease retropatellar contact pressure due to changes in pelvis inclination and available hip rotation. Specifically, resistance to knee flexion is purported to increase hamstring activity and inhibit the activity of the tensor fasciae latae and psoas muscles. The manufacturer asserts that prolonged use of the system results in greater hamstring activation, which leads to permanent structural changes through reciprocal inhibition at the hip and pelvis. The warm-up consisted of the subject wearing the ProtonicsTM knee brace set at a moderate resistance level and flexing the knees while sitting, standing, and reclining in the supine and prone positions.
Study NCT03915782 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning
Description: Remote ischemic conditioning (RIC): Four cycles of \[5 minutes of brachial cuff inflation at 200 millimeters (mm) of mercury (Hg) followed by 5 minutes of cuff deflation\] started as soon as possible after Magnetic Resonance Imaging (MRI).
Study NCT03915782 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Patients with a sham procedure of remote ischemic conditioning
Description: Sham procedure: Four cycles of \[5 minutes of brachial cuff inflation at 30 millimeters (mm) of mercury (Hg) followed by 5 minutes of cuff deflation\] started as soon as possible after Magnetic Resonance Imaging (MRI).
Study NCT05878197 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Straw phonation
Description: The two experimental groups will receive either straw phonation therapy or resonant voice therapy. The hierarchical structure of the therapy sessions will be equal for the three programs. In each session, vocal rest pauses will be foreseen by playing games, performing drawing assignments, etc. This will make the therapy more pleasant and less intensive. All voice therapy programs will be guided by the same experienced voice therapist.~Content:~Day 1: counseling (anatomy and physiology of the voice and vocal fold nodules), vocal hygiene recommendations (water intake, avoiding vocal misuse and abuse) Day 2: breathing exercises, vocal hygiene recommendations, straw phonation on vowel and syllable level, pitch variations Day 3: breathing exercises, vocal hygiene recommendations, straw phonation on word and sentence level, pitch variations Day 4: straw phonation in spontaneous speech, combination exercises
Study NCT05878197 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Resonant voice therapy
Description: The two experimental groups will receive either straw phonation therapy or resonant voice therapy. The hierarchical structure of the therapy sessions will be equal for the three programs. In each session, vocal rest pauses will be foreseen by playing games, performing drawing assignments, etc. This will make the therapy more pleasant and less intensive. All voice therapy programs will be guided by the same experienced voice therapist.~Content:~Day 1: counseling (anatomy and physiology of the voice and vocal fold nodules), vocal hygiene recommendations (water intake, avoiding vocal misuse and abuse) Day 2: breathing exercises, vocal hygiene recommendations, resonant voice therapy on vowel and syllable level, pitch variations Day 3: breathing exercises, vocal hygiene recommendations, resonant voice therapy on word and sentence level, pitch variations Day 4: resonant voice therapy in spontaneous speech, combination exercises
Study NCT05878197 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Vocal Hygiene
Description: Participants of the control group will receive a sham treatment, including the exact same games, drawing assignments, etc. as in the experimental groups. However, no SOVT or other active vocal techniques will be practiced. Vocal hygiene guidelines (e.g. avoid screaming, imitating voices, sufficient hydration etc.) will be kept equally in the four groups. All voice therapy programs will be guided by the same experienced voice therapist.~Content:~Day 1: counseling (anatomy and physiology of the voice and vocal fold nodules), vocal hygiene recommendations (water intake, avoiding vocal misuse and abuse) Day 2: breathing exercises, vocal hygiene recommendations Day 3: breathing exercises, vocal hygiene recommendations Day 4: combination exercises
Study NCT03042559 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sports Cords
Description: Subjects assigned to the sport cord group were asked to do the same warm-ups and exercises using the sport cord in the supine, standing, sitting, and prone positions. prone. The only difference is that subjects were asked to only walk backwards instead of forwards in order to avoid activation of the hip flexor muscle. The appropriate level of resistance for each subject was calculated by multiplying their weight in pounds by 0.3. Subjects were then given either light, medium, or heavy resistance cords according to the following classification scheme: light (pink color) with resistance 3 (R3), 0-30 lbs.; medium (orange color) with resistance 5 (R5) 0-50 lbs.; heavy (yellow color) with resistance 7 (R7) 0-70 lbs. All subjects completed three study visits, and a total of four measurements were taken at baseline, immediately following the first session, at two weeks, and at 4 weeks.
Study NCT03520322 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mastoid Oscillator
Description: The oscillator will be placed over the mastoid of their involved ear and secured via an elastic/Velcro headband. The subject is positioned so as to place the endolymphatic duct into a gravitationally dependent orientation (the subject lying on their contralateral side with the face slightly tilted towards the floor). The device is turned on and operated for 30 minutes.
Study NCT03520322 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Control Device
Description: The control device will be placed over the mastoid of their involved ear and secured via an elastic/Velcro headband. The subject is positioned so as to place the endolymphatic duct into a gravitationally dependent orientation (the subject lying on their contralateral side with the face slightly tilted towards the floor). The device is turned on and operated for 30 minutes.
Study NCT00561392 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rivastigmine 5 and 10 cm^2 patch
Study NCT06752005 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intervention Group
Description: One of the investigators created a randomization sequence using a simple random numbers table and determined the groups. Another researcher assigned premature infants to the study groups according to the order of hospitalization in the unit, and the same researcher also applied the intervention. Thus, each infant experienced all three positions in a crossover design by the end of the study. Infants in all three groups were positioned for two hours in each posture, totaling six hours by the end of the study. Immediately after positioning in each posture, and at 1, 30, 60, 90, and 120 minutes, heart rate and oxygen saturation (SpO₂) values were recorded from bedside monitors, and respiratory rate was counted over one minute. Comfort and stress scores were assessed immediately after positioning (1 minute) and at 60 and 120 minutes. The Premature Infant Comfort Scale (PICS) was used to assess comfort, while the Neonatal Stress Scale (NSS) was used to evaluate stress.
Study NCT03963232 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Galcanezumab
Description: Administered SC
Study NCT03963232 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Administered SC
Study NCT04866758 — intervention group
Intervention type: OTHER
Intervention: Survey
Description: All data gathered will be quantitative in nature. In addition to participant completed surveys, additional demographic, and diagnosis/treatment related information will be collected from the patient's electronic medical record via Health Data Compass. Subsequent data collected as part of the patient's standard psychosocial and cancer related care (i.e., health outcomes, future utilization of UCCC psychosocial services) will also be gathered. This subsequent data collection will not include further participation, but continued access to the patient's medical record. Protected health information collected for this project will include dates (e.g., birth dates, date of diagnosis, date since last treatment, death dates) and participant zip codes. No other identifiable data will be collected. A separate survey emailed to the participant at the end of the study will collect information regarding the participant's completion status of the survey.
Study NCT01905917 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tele-rehabilitation
Study NCT03178188 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Pulsed-dye Laser
Description: 595 nm Pulsed-dye Laser; 7mm spot sizes, 6msec pulse durations, 8j/cm2 fluences, dynamic cooling device 30/20, 4 sessions with 4 weeks interval
Study NCT03178188 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham
Description: Cryogen spray with the setting of dynamic cooling device 30/20
Study NCT00795002 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: alvocidib
Description: Given IV
Study NCT00795002 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: mitoxantrone hydrochloride
Description: Given IV
Study NCT00795002 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cytarabine
Description: Given IV
Study NCT00795002 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: pharmacological study
Description: Correlative studies
Study NCT00795002 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: laboratory biomarker analysis
Description: Correlative studies
Study NCT04431349 — intervention group
Intervention type: DRUG
Intervention: Ticagrelor 180mg
Description: Patient received loading dose of ticagrelor for coronary angiography within 2 days prior to OPCAB or CABG.
Study NCT00683514 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Oral Vinorelbine and cisplatin with concomitant radiotherapy 66 Gy (total dose)
Description: q 28 days :~* 50 mg/m2 oral vinorelbine d1, d8, d15~* 20 mg/m2/d cisplatin from d1 to d4
Study NCT00683514 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Oral Vinorelbine and cisplatin with concomitant radiotherapy 66 Gy (total dose)
Description: q 21 days :~* 60 mg/m2 oral vinorelbine d1,d8 for cycle 1 or 80 mg/m2 oral vinorelbine d1,d8 for cycle 2~* 80 mg/m2 cisplatin d1
Study NCT03074097 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bupivacaine 0.25%
Description: Each patient received bilateral single shot ultrasound guided rectus sheath block under complete aseptic condition in a dose of 30 ml of bupivacaine 0.25% in each side immediately after induction of general anaesthesia
Study NCT04431349 — intervention group
Intervention type: DRUG
Intervention: Clopidogrel 75mg
Description: Patient received loading dose of clopidogrel for coronary angiography within 2 days prior to OPCAB or CABG.
Study NCT02428309 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Ex vivo Expanded Human Autologous Polyclonal Regulatory T Cells
Study NCT03194880 — intervention group
Intervention type: DEVICE
Intervention: AlereCOMBO and Alere q Detect
Description: The feasibility assessment will comprise of two components:~1. User's perspective: A questionnaire will be developed and used to assess the level of satisfaction among community health workers performing the two new tests, using a 5 point Likert scale. We will assess the training and manual, the use of the test, the user's confidence, troubleshooting and technical support components and resolving problems.~2. The laboratory component: For each test we will evaluate:~   * The percentage of assays completed~  * The percentage of assays incomplete (i.e. invalid result on two attempts)~  * Reasons for incomplete assays, e.g.~     * The sample could not be delivered to the strip or cartridge correctly~    * Invalid control~    * Results could not be interpreted~    * Others
Study NCT02787135 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: emotion-oriented Cognitive Behavior Therapy
Description: Emotion-oriented Cognitive Behavior Therapy with a focus on delusions: Aim of the intervention is to change factors that are involved in the formation and maintenance of delusions: emotional stability and regulation of negative emotions, sleep quality and self-esteem.